XTENT
Menlo Park
About XTENT
Xtent is a development stage medical device company focused on developing and commercializing their innovative customizable drug eluting stent systems for the treatment of coronary artery disease, or CAD. Their drug eluting stent systems are designed to enable physicians to customize both length and diameter of the stent at the site of the diseased section of the artery, or lesion, which we refer to as in-situ customization.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Delisted
- Employees: 51 – 100
- Total funding: $44.0M
- Funding stage: IPO
- Last round: Post-IPO Equity (Nov 2016)
- Ticker: nasdaq:XTNT
- Website: xtentinc.com
Industries & Categories
Health Care, Manufacturing, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/xtent-2224479 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.